We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+14.35%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$56.5B
AUM Growth
+$9.69B
Cap. Flow
+$2.96B
Cap. Flow %
5.25%
Top 10 Hldgs %
7.66%
Holding
3,681
New
509
Increased
1,200
Reduced
1,275
Closed
531

Top Buys

Rank Stock Value
1
IGV icon
iShares Expanded Tech-Software Sector ETF
IGV
+$312M
2
UNH icon
UnitedHealth
UNH
+$286M
3
DUOL icon
Duolingo
DUOL
+$247M
4
AON icon
Aon
AON
+$226M
5
CB icon
Chubb
CB
+$221M

Sector Composition

Rank Sector Weight
1 Technology 16.79%
2 Financials 14.46%
3 Healthcare 12.9%
4 Consumer Discretionary 8.97%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABR icon
3076
Arbor Realty Trust
ABR
$968M
-72,224
Closed -$761K
ACLX
3077
DELISTED
Arcellx
ACLX
-6,900
Closed -$453K
ADAP
3078
DELISTED
Adaptimmune Therapeutics
ADAP
-135,947
Closed -$26.8K
ADCT icon
3079
ADC Therapeutics
ADCT
$127M
-44,686
Closed -$63K
AEHR icon
3080
Aehr Test Systems
AEHR
$3.32B
-48,984
Closed -$357K
AEMD icon
3081
Aethlon Medical
AEMD
$1.94M
-57
Closed -$8.13K
AEYE icon
3082
AudioEye
AEYE
$90.5M
-13,391
Closed -$149K
AHCO icon
3083
AdaptHealth
AHCO
$751M
-110,971
Closed -$1.2M
AIRI icon
3084
Air Industries Group
AIRI
$11.9M
-13,878
Closed -$48.3K
AKAM icon
3085
PUT
Akamai
AKAM
$15.9B
-75,900
Closed -$6.11M
AKRO
3086
DELISTED
Akero Therapeutics
AKRO
-62,020
Closed -$2.51M
ALKT icon
3087
Alkami Technology
ALKT
$2.18B
-54,218
Closed -$1.42M
ALLE icon
3088
Allegion
ALLE
$13.8B
-117,009
Closed -$15.3M
ALLK
3089
DELISTED
Allakos
ALLK
-74,270
Closed -$16.9K
ANGI icon
3090
Angi Inc
ANGI
$200M
-35,897
Closed -$553K
ANIP icon
3091
ANI Pharmaceuticals
ANIP
$1.73B
-14,079
Closed -$943K
ANVS icon
3092
Annovis Bio
ANVS
$77.5M
-166,219
Closed -$249K
APD icon
3093
Air Products & Chemicals
APD
$67.9B
-4,921
Closed -$1.45M
APP icon
3094
Applovin
APP
$102B
-31,700
Closed -$8.4M
ARAY icon
3095
Accuray
ARAY
$33.6M
-35,028
Closed -$62.7K
ARCO icon
3096
Arcos Dorados Holdings
ARCO
$1.68B
-314,672
Closed -$2.54M
ARVN icon
3097
Arvinas
ARVN
$613M
-128,247
Closed -$900K
ASH icon
3098
Ashland
ASH
$3.33B
-29,553
Closed -$1.75M
ASLE icon
3099
AerSale
ASLE
$265M
-10,028
Closed -$75.1K
ASTE icon
3100
Astec Industries
ASTE
$1B
-18,145
Closed -$625K

Similar funds

John Overdeck's Q2 2025 Portfolio in Review

As of Q2 2025, John Overdeck held 3,681 positions worth $56.5B, up 21% from $46.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

John Overdeck deployed $2.96B of net new capital in Q2 2025, opening 509 new positions and adding to 1,200 existing holdings. Its largest new stake was iShares Expanded Tech-Software Sector ETF: 3,154,300 shares worth $345M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Broadcom, an estimated $338M trimmed.

  • John Overdeck's largest Q2 2025 buy was iShares Expanded Tech-Software Sector ETF: 3,154,300 shares worth $345M.
  • John Overdeck added most to UnitedHealth in Q2 2025, an estimated $286M increase.
  • John Overdeck's biggest Q2 2025 reduction was Broadcom, cutting an estimated $338M.
  • John Overdeck fully exited State Street Utilities Select Sector SPDR ETF in Q2 2025, selling an estimated $134M.
  • John Overdeck's ten largest holdings make up 7.7% of its $56.5B portfolio in Q2 2025.
  • John Overdeck opened 509 new positions and closed 531 in Q2 2025.
  • John Overdeck's portfolio value rose 21% quarter-over-quarter to $56.5B.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.